Lintaz

Main information

  • Trade name:
  • Lintaz 2g / 250 mg Powder for Injection (IV)
  • Dosage:
  • 2g / 250 mg
  • Pharmaceutical form:
  • Powder for Injection (IV)
  • Units in package:
  • 20mL USP Type I Clear Glass Vial + 10mL USP Type I Clear Glass Ampoule (Diluent) (Box of 1's)
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug
  • Manufactured by:
  • Scott-Edil Pharmacia Limited

Documents

Localization

  • Available in:
  • Lintaz 2g / 250 mg Powder for Injection (IV)
    Philippines
  • Language:
  • English

Status

  • Source:
  • FDA - Food And Drug Administration - Philippines
  • Authorization number:
  • DRP-6004-02
  • Authorization date:
  • 17-02-2020
  • Last update:
  • 15-01-2018